Cyclin D1/CCND1 Antibody (YA3900)

Cyclin D1/CCND1 Antibody (YA3900) is a mouse-derived and non-conjugated IgG1 antibody, targeting to CCND1. It can be applicated for IHC-P, ICC/IF, FC, ELISA assays, in the background of human.

The CCND1 protein functions as a regulatory component of the cyclin D1-CDK4 (DC) complex, orchestrating phosphorylation and inhibition of retinoblastoma (RB) family members, including RB1, to modulate cell-cycle progression during G(1)/S transition. This phosphorylation event prompts the dissociation of the transcription factor E2F from the RB/E2F complex, facilitating the transcription of E2F target genes essential for G(1) phase progression. CCND1 also exhibits hypophosphorylation activity on RB1 in early G(1) phase. Serving as a major integrator of mitogenic and antimitogenic signals, cyclin D-CDK4 complexes, including CCND1, play a pivotal role in cell-cycle regulation. Additionally, CCND1 engages in interactions with various proteins, such as SMAD3, forming a ternary complex with CDK4 and CDKN1B, and displaying transcriptional corepressor activity with INSM1. These intricate interactions contribute to the nuanced regulatory functions of CCND1 in cellular processes.

P24385

Predicted band size: 34 kDa; Observed band size: 34 kDa

affinity purified.

Non-conjugated

Primary Antibody; Mouse Monoclonal Antibody

Mouse

Human

IHC: 1/200-1/1000; IF: 1/100-1/500; FC: 1/200-1/400; ELISA: 1/10000

IHC-P, ICC/IF, FC, ELISA

Liquid

Supplied in PBS with 0.05% sodium azide

Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.

Shipping with blue ice.

IgG1

Purified recombinant fragment of human CCND1 (AA: 167-295) expressed in E. Coli.